Jump to navigation
A world first Australian study has found that psychostimulant use plays a major role in stroke deaths occurring before age 45.
A delegation from the Republic of Indonesia National Narcotics Board (BNN) visited NDARC in August as part of a study tour.
NCETA was invited to present to a workshop of the Adelaide PHN’s newly established AOD Special Interest Areas (SIA) group.
Professor Julie Bruneau, lead author of a recently published national Canadian guideline for treating opioid use disorders will speak at the NDARC Annual Research Symposium.
Professor Louis Fiore from the Boston University School of Medicine will share his experience and knowledge of point of care clinical trials at NDARC's Annual Research Symposium.
The National Centre for Clinical Research on Emerging Drugs (NCCRED) has been established to support the provision of clinical treatment interventions to people experiencing problems related to the
Over the past three years, NCETA has partnered with the Queen Elizabeth Hospital’s Clinical Education Centre to conduct a one-day workshop for medical, nursing and allied health staff on identifyin
Many prescribers in Australia have patients experiencing difficulties with their use of pharmaceutical opioids.
NCETA was invited by Business SA to participate in the launch, on Friday 27 July, 2018, of their Ice at Work white paper dealing with methamphetamine and other drug use in the workplace.
Register for NDRI’s 2018 Annual Symposium, this year taking place in Melbourne on Thursday 22 November.
The winner of the National Competition for Excellence in Hepatitis C Health Promotion was announced by CSRH and NDRI on World Hepatitis Day 2018.
The national centres are supported by funding from the Australian Government under the Drug and Alcohol Program
Page last updated: Monday 8 April 2019